Grantham, Mayo, Van Otterloo & Co (GMO)
SGEN

Grantham, Mayo, Van Otterloo & Co (GMO)’s Seagen Inc. Common Stock SGEN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-168,935
Closed -$35.8M – 602
2023
Q3 		$35.8M Buy
168,935
+122,656
+265% +$24.5M 0.17% 109
2023
Q2 		$8.91M Buy
+46,279
New +$9.19M 0.04% 269

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SGEN Position: Q4 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 168,935 shares — an estimated $35.8M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SGEN in Q2 2023 and held it in 2 quarters. The position peaked at $35.8M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 168,935 Seagen Inc. Common Stock shares in Q4 2023, an estimated $35.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Seagen Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Seagen Inc. Common Stock position peaked at $35.8M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2023, filed 13 Feb 2024.